Menu
Back to Archived Journals » Core Evidence » Volume 8
Review
Lapatinib plus chemotherapy or endocrine therapy (CET) versus CET alone in the treatment of HER-2-overexpressing locally advanced or metastatic breast cancer: systematic review and meta-analysis
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 10,567 | Dovepress* | 9,325+ | 1,637 | 10,962 | |
| PubMed Central* | 1,242 | 474 | 1,716 | ||
| Totals | 10,567 | 2,111 | 12,678 | ||
|
*Since 30 September 2013 +Since July 2016 |
|||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 8 | 2 | 0 | 0 | 2 | 4 |
View citations on PubMed Central and Google Scholar